400 related articles for article (PubMed ID: 30484022)
1. Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018).
Dai L; Cheng CW; Tian R; Zhong LL; Li YP; Lyu AP; Chan AW; Shang HC; Bian ZX
Chin J Integr Med; 2019 Jan; 25(1):71-79. PubMed ID: 30484022
[TBL] [Abstract][Full Text] [Related]
2. CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration.
Li J; Hu JY; Zhai JB; Niu JQ; Kwong JSW; Ge L; Li B; Wang Q; Wang XQ; Wei D; Tian JH; Ma B; Yang KH; Dai M; Tian GH; Shang HC;
Complement Ther Med; 2019 Oct; 46():180-188. PubMed ID: 31519276
[TBL] [Abstract][Full Text] [Related]
3. Are Published Cancer Care Trial Protocols With Traditional Chinese Medicine Interventions Concordant With SPIRIT-TCM Extension 2018? A Scoping Review on Published Trial Protocols Between 2019 and 2022.
Lai H; Yang P; Wang XS; Lim D; Lam A; Shi Y; Huang Y; Zhu X
Integr Cancer Ther; 2024; 23():15347354231223966. PubMed ID: 38291957
[TBL] [Abstract][Full Text] [Related]
4. WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration.
Zhang X; Lan L; Chan JCP; Zhong LLD; Cheng CW; Lam WC; Tian R; Zhao C; Wu TX; Shang HC; Lyu AP; Bian ZX
BMC Med Res Methodol; 2020 Jul; 20(1):192. PubMed ID: 32680474
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
[TBL] [Abstract][Full Text] [Related]
7. Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study.
Zhang L; Li H; Hu L; Ou X; Tan H; Zhang X; Lau CT; Lyu A; Bian Z; Zhang X
Front Pharmacol; 2024; 15():1389808. PubMed ID: 38910893
[TBL] [Abstract][Full Text] [Related]
8. The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation.
Xie R; Xia Y; Chen Y; Li H; Shang H; Kuang X; Xia L; Guo Y
Pharmacol Res; 2020 Oct; 160():105178. PubMed ID: 32889127
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension.
Rivera SC; Liu X; Chan AW; Denniston AK; Calvert MJ;
BMJ; 2020 Sep; 370():m3210. PubMed ID: 32907797
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ; ; ;
Nat Med; 2020 Sep; 26(9):1351-1363. PubMed ID: 32908284
[TBL] [Abstract][Full Text] [Related]
12. Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol.
Zhang M; Chua HZ; Zhang J; Niu B; Zheng W; Li K; Zhang B
BMJ Open; 2021 Jul; 11(7):e047148. PubMed ID: 34215606
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese medicine for insomnia: Recommendation mapping of the global clinical guidelines.
Ye Z; Lai H; Ning J; Liu J; Huang J; Yang S; Jin J; Liu Y; Liu J; Zhao H; Ge L
J Ethnopharmacol; 2024 Mar; 322():117601. PubMed ID: 38122913
[TBL] [Abstract][Full Text] [Related]
14. Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.
Kahan BC; Hall SS; Beller EM; Birchenall M; Elbourne D; Juszczak E; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Chan AW; Montgomery AA
JAMA Netw Open; 2023 Dec; 6(12):e2346121. PubMed ID: 38051535
[TBL] [Abstract][Full Text] [Related]
15. Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries.
Zhang X; Tian R; Yang Z; Zhao C; Yao L; Lau C; Wu T; Shang H; Zhang X; Lu A; Bian Z
BMJ Open; 2019 Feb; 9(2):e025218. PubMed ID: 30782928
[TBL] [Abstract][Full Text] [Related]
16. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
Chan AW; Tetzlaff JM; Gøtzsche PC; Altman DG; Mann H; Berlin JA; Dickersin K; Hróbjartsson A; Schulz KF; Parulekar WR; Krleza-Jeric K; Laupacis A; Moher D
BMJ; 2013 Jan; 346():e7586. PubMed ID: 23303884
[TBL] [Abstract][Full Text] [Related]
17. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020).
Zhang X; Tan R; Lam WC; Yao L; Wang X; Cheng CW; Liu F; Chan JC; Aixinjueluo Q; Lau CT; Chen Y; Yang K; Wu T; Lyu A; Bian Z
Am J Chin Med; 2020; 48(6):1279-1313. PubMed ID: 32907365
[TBL] [Abstract][Full Text] [Related]
18. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
Trials; 2015 Sep; 16():417. PubMed ID: 26385379
[TBL] [Abstract][Full Text] [Related]
19. [Herbal CONSORT statement and standardization of reporting traditional Chinese drug trials].
Fei YT; Liu JP
Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):89-94. PubMed ID: 18338628
[TBL] [Abstract][Full Text] [Related]
20. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
Calvert M; King M; Mercieca-Bebber R; Aiyegbusi O; Kyte D; Slade A; Chan AW; Basch E; Bell J; Bennett A; Bhatnagar V; Blazeby J; Bottomley A; Brown J; Brundage M; Campbell L; Cappelleri JC; Draper H; Dueck AC; Ells C; Frank L; Golub RM; Griebsch I; Haywood K; Hunn A; King-Kallimanis B; Martin L; Mitchell S; Morel T; Nelson L; Norquist J; O'Connor D; Palmer M; Patrick D; Price G; Regnault A; Retzer A; Revicki D; Scott J; Stephens R; Turner G; Valakas A; Velikova G; von Hildebrand M; Walker A; Wenzel L
BMJ Open; 2021 Jun; 11(6):e045105. PubMed ID: 34193486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
